Literature DB >> 33990624

Dementia epidemiology in Hungary based on data from neurological and psychiatric specialty services.

Nóra Balázs1, András Ajtay1,2, Ferenc Oberfrank3, Dániel Bereczki1,2, Tibor Kovács4,5.   

Abstract

Hungary has a single-payer health insurance system covering 10 million inhabitants. All medical reports of the in- and outpatient specialist services were collected in the NEUROHUN database. We used ICD-10 codes of Alzheimer's disease (AD), vascular dementia (VaD), miscellaneous dementia group and mild cognitive impairment (MCI) for the inclusion of the patients. Incidence, prevalence and survival of different dementias and MCI were calculated and analyzed depending on the diagnoses given by neurological or psychiatric services or both. Between 2011 and 2016, the mean crude incidence of all dementias was 242/100,000/year, whereas the age standardized incidence was 287/100,000/year. Crude and age standardized mean prevalence rates were 570/100,000 and 649/100,000, respectively. There were significantly more VaD diagnoses than AD, the VaD:AD ratio was 2.54:1, being the highest in patients with psychiatric diagnoses only (4.85:1) and the lowest in patients with only neurological diagnoses (1.32:1). The median survival after the first diagnosis was 3.01 years regarding all dementia cases. Compared to international estimates, the prevalence of dementia and MCI is considerably lower in Hungary and the VaD:AD ratio is reversed.

Entities:  

Year:  2021        PMID: 33990624     DOI: 10.1038/s41598-021-89179-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  24 in total

Review 1.  Epidemiological studies of cognitive impairment and dementia across Eastern and Middle European countries (epidemiology of dementia in Eastern and Middle European Countries).

Authors:  A Kiejna; D Frydecka; T Adamowski; H Bickel; E Reynish; M Prince; B Caracciolo; L Fratiglioni; J Georges
Journal:  Int J Geriatr Psychiatry       Date:  2011-02       Impact factor: 3.485

Review 2.  The global prevalence of dementia: a systematic review and metaanalysis.

Authors:  Martin Prince; Renata Bryce; Emiliano Albanese; Anders Wimo; Wagner Ribeiro; Cleusa P Ferri
Journal:  Alzheimers Dement       Date:  2013-01       Impact factor: 21.566

Review 3.  A clinicopathological approach to the diagnosis of dementia.

Authors:  Fanny M Elahi; Bruce L Miller
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

4.  Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013.

Authors:  Richard A Goodman; Kimberly A Lochner; Madhav Thambisetty; Thomas S Wingo; Samuel F Posner; Shari M Ling
Journal:  Alzheimers Dement       Date:  2016-05-10       Impact factor: 21.566

5.  Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

Authors:  A Lobo; L J Launer; L Fratiglioni; K Andersen; A Di Carlo; M M Breteler; J R Copeland; J F Dartigues; C Jagger; J Martinez-Lage; H Soininen; A Hofman
Journal:  Neurology       Date:  2000       Impact factor: 9.910

Review 6.  Alzheimer disease as a vascular disorder: nosological evidence.

Authors:  J C de la Torre
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

Review 7.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

8.  Demand for neurological services in Central Eastern Europe: a 10-year national survey in Hungary.

Authors:  F Oberfrank; A Ajtay; D Bereczki
Journal:  Eur J Neurol       Date:  2018-04-18       Impact factor: 6.089

Review 9.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

10.  Mixed dementia: A review of the evidence.

Authors:  Nilton Custodio; Rosa Montesinos; David Lira; Eder Herrera-Pérez; Yadira Bardales; Lucía Valeriano-Lorenzo
Journal:  Dement Neuropsychol       Date:  2017 Oct-Dec
View more
  1 in total

1.  Cholinesterase inhibitors for the treatment of dementia: real-life data in Hungary.

Authors:  Nóra Balázs; Dániel Bereczki; András Ajtay; Ferenc Oberfrank; Tibor Kovács
Journal:  Geroscience       Date:  2021-10-15       Impact factor: 7.713

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.